{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:53:09Z","timestamp":1778237589674,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.intimp.2005.09.011","type":"journal-article","created":{"date-parts":[[2005,10,15]],"date-time":"2005-10-15T11:11:00Z","timestamp":1129374660000},"page":"454-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Synergism in immunotoxicological effects due to repeated combined administration of arsenic and lead in mice"],"prefix":"10.1016","volume":"6","author":[{"given":"B.","family":"Bishayi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2005.09.011_bib1","series-title":"Laboratory diagnosis of diseases caused by toxic agents","first-page":"367","article-title":"Inorganic arsenic intoxication","volume":"vol. 1970","author":"Kyle","year":"1970"},{"key":"10.1016\/j.intimp.2005.09.011_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/BF02098038","article-title":"Effect of lead on polymorphonuclear leukocyte function in occupationally exposed workers","volume":"65","author":"Valentino","year":"1991","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.intimp.2005.09.011_bib3","first-page":"281","article-title":"Mechanism of arsenic carcinogenecity: genetic or epigenetic mechanisms","volume":"19","author":"Simeonova","year":"2000","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"10.1016\/j.intimp.2005.09.011_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1081\/ESE-120016886","article-title":"Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal","volume":"38","author":"Guha mazumder","year":"2003","journal-title":"J Environ Sci Health Part A"},{"key":"10.1016\/j.intimp.2005.09.011_bib5","first-page":"1045","article-title":"Arsenic and respiratory cancer in man: an occupational study","volume":"42","author":"Lee","year":"1969","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.intimp.2005.09.011_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1289\/ehp.02110331","article-title":"Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water","volume":"110","author":"Pi","year":"2002","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.intimp.2005.09.011_bib7","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1289\/ehp.6332","article-title":"Arsenic exposure accelerates atherogenesis in ApoE\u2212\/\u2212 mice","volume":"111","author":"Simenova","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.intimp.2005.09.011_bib8","series-title":"Biological and environmental effects of arsenic","first-page":"233","article-title":"The toxicity of arsenic and its compounds","author":"Squibb","year":"1983"},{"key":"10.1016\/j.intimp.2005.09.011_bib9","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1002\/j.1460-2075.1996.tb01017.x","article-title":"The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase","volume":"15","author":"Cavigeli","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.intimp.2005.09.011_bib10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0891-5849(99)00186-0","article-title":"Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenic","volume":"27","author":"Barchowsky","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.intimp.2005.09.011_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0891-5849(96)00501-1","article-title":"Redox regulation of NF-kappa B activation","volume":"22","author":"Flohe","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.intimp.2005.09.011_bib12","series-title":"Fundamental toxicology for chemists","first-page":"175","article-title":"Behavioural toxicology","author":"Winneke","year":"1996"},{"key":"10.1016\/j.intimp.2005.09.011_bib13","series-title":"The pharmacological basis of therapeutics","first-page":"1650","article-title":"Heavy metals and heavy metal antagonists","author":"Klaassen","year":"1996"},{"key":"10.1016\/j.intimp.2005.09.011_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/taap.1995.1096","article-title":"Lead inhibits nitric oxide production in vitro by murine splenic macrophages","volume":"137","author":"Tian","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.intimp.2005.09.011_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0041-008X(88)90007-5","article-title":"Immunomodulation of in vitro antigen presentation by cations","volume":"96","author":"Smith","year":"1988","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.intimp.2005.09.011_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1081\/DCT-120014796","article-title":"Effect of lead and arsenic on murine macrophage response","volume":"25","author":"Sengupta","year":"2002","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.intimp.2005.09.011_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0300-483X(02)00549-8","article-title":"Intracellular survival of Staphylococcus aureus due to alteration of cellular activity in arsenic and lead intoxicated mature Swiss albino mice","volume":"184","author":"Bishayi","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2005.09.011_bib18","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1128\/iai.65.9.3889-3895.1997","article-title":"Correlation of histopathologic and bacteriologic changes with cytokine expression in experimental murine model of bacteremic Staphylococcus aureus infection","volume":"65","author":"Yao","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2005.09.011_bib19","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/iai.62.7.2806-2810.1994","article-title":"Presence of a capsule in Erysiophelothrix rhusiopathiae and its relationship to virulence for mice","volume":"62","author":"Shimoji","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2005.09.011_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0041-008X(91)90296-Q","article-title":"Splenic cell targets in gallium, arsenic and lead induced suppression of primary antibody response","volume":"110","author":"Sikorski","year":"1991","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.intimp.2005.09.011_bib21","doi-asserted-by":"crossref","first-page":"16189","DOI":"10.1074\/jbc.270.27.16189","article-title":"Integrin mediated tyrosine phosphorylation and message induction in monocytic cells","volume":"270","author":"Lin","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2005.09.011_bib22","first-page":"2952","article-title":"Lack of effect of recombinant platelet derived growth on human neutrophil function","volume":"159","author":"Qu","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2005.09.011_bib23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/IAI.66.3.1017-1022.1998","article-title":"Protective role of nitric oxide in S. aureus infection in mice","volume":"66","author":"Sasaki","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2005.09.011_bib24","series-title":"Handbook of experimental immunology","first-page":"46.1","article-title":"In vitro determination of phagocytosis and intracellular killing by polymorphonuclear neutrophils and mononuclear phagocytes","author":"Leigh","year":"1986"},{"key":"10.1016\/j.intimp.2005.09.011_bib25","series-title":"Handbook of experimental immunology","first-page":"51.1","article-title":"Locomotion and chemotaxis of leukocytes","author":"Wilkinson","year":"1986"},{"key":"10.1016\/j.intimp.2005.09.011_bib26","first-page":"4133","article-title":"Characterization and quantification of the peroxidase in human neutrophils","volume":"525","author":"Bos","year":"1990","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.intimp.2005.09.011_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/iai.65.1.35-41.1997","article-title":"Butyric acid induced apoptosis of murine thymocytes, Splenic T cells, and Jurkat T cells","volume":"65","author":"Ochiai","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2005.09.011_bib28","first-page":"1251","article-title":"Zero-interaction response surfaces, interaction functions and difference response surfaces for combinations of biologically active agents","volume":"42","author":"Suhnel","year":"1992","journal-title":"Arzneimittelforscung-Drug Research"},{"key":"10.1016\/j.intimp.2005.09.011_bib29","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905002626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576905002626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T20:38:33Z","timestamp":1742243913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576905002626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1567576905002626"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2005.09.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergism in immunotoxicological effects due to repeated combined administration of arsenic and lead in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2005.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}